Claire Mazumdar
Tracked across 1 events · 40 articles · First seen May 05, 2026 · Last active May 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Claire Mazumdar has been named as the future successor to Kiran Mazumdar-Shaw at Biocon and is currently the CEO of Bicara Therapeutics, a company she led to a market capitalization exceeding $1.6 billion.
May 05, 2026 · 40 articles
ERGEN INTELLIGENCE
Track Claire Mazumdar live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard